Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study.
Jyoutishman SaikiaPrabhat S MalikSachin KumarDeepali JainKaran MadanSachidanand Jee BharatiSuryanarayana S V DeoSunila KumarPublished in: Journal of surgical oncology (2024)
Among patients with operable NSCLC, it is feasible to identify cfDNA in pleural lavage and correlate PLV cfDNA with pleural recurrences and outcomes.